1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Bioreactors Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rapid growth of biopharmaceuticals and biologics industries
5.1.1.2. Adoption of single-use bioreactors (subs) and hybrid bioreactors
5.1.2. Restraints
5.1.2.1. Maintenance issues and high power consumption issues with bioreactors
5.1.3. Opportunities
5.1.3.1. Continuous technological advancements in the development of novel bioreactors
5.1.3.2. High potential of bioreactors in the wastewater treatment process
5.1.4. Challenges
5.1.4.1. Safety and environmental concerns associated with the use of bioreactors
5.2. Market Segmentation Analysis
5.2.1. Mechanism: Adoption of photo-bioreactors for the growth of photosynthetic microorganisms
5.2.2. Usage: Preferences for full-scale production from various industries due to large volume processing capacity
5.2.3. Control Type: Adoption of automated bioreactors due to high level of precision and consistency in process control
5.2.4. Material : Increasing usage of stainless steel bioreactors in the pharmaceutical and biotech industries owing to their durability and scalability
5.2.5. Scale: Suitability of 200L-1500L bioreactors for pilot-scale and small-scale commercial manufacturing processes
5.2.6. Usability: Preferences for single-use bioreactors due to their flexibility, & reduced risk of cross-contamination
5.2.7. End User: Increasing applicability in biopharmaceutical industry, for producing biotherapeutics including monoclonal antibodies & vaccines
5.3. Market Trend Analysis
5.3.1. Emphasis on R&D activities for advanced bioreactors with the support of established production facilities in the Americas
5.3.2. Supportive government initiatives and enhanced technology adoption in drug manufacturing
5.3.3. Vigorous biopharmaceutical research activities and well-established players in the region
5.4. Cumulative Impact of COVID-19
5.5. Cumulative Impact of Russia-Ukraine Conflict
5.6. Cumulative Impact of High Inflation
5.7. Porter’s Five Forces Analysis
5.7.1. Threat of New Entrants
5.7.2. Threat of Substitutes
5.7.3. Bargaining Power of Customers
5.7.4. Bargaining Power of Suppliers
5.7.5. Industry Rivalry
5.8. Value Chain & Critical Path Analysis
5.9. Regulatory Framework
6. Bioreactors Market, by Mechanism
6.1. Introduction
6.2. Airlift Bioreactors
6.3. Benchtop Bioreactors
6.4. Bubble Column Bioreactors
6.5. Continuous Stirred Tank Bioreactors
6.6. Fluidized Bed Bioreactors
6.7. Microbial Bioreactors
6.8. Multi-Parallel Bioreactors
6.9. Packed Bed Bioreactors
6.10. Photo-Bioreactors
7. Bioreactors Market, by Usage
7.1. Introduction
7.2. Full-scale Production
7.3. Lab-Scale Production
7.4. Pilot-scale Production
8. Bioreactors Market, by Control Type
8.1. Introduction
8.2. Automated
8.3. Manual
9. Bioreactors Market, by Material
9.1. Introduction
9.2. Glass
9.3. Stainless Steel
10. Bioreactors Market, by Scale
10.1. Introduction
10.2. 1500L-4000L
10.3. 200L-1500L
10.4. 20L-200L
10.5. 5L-20L
10.6. Above 4000L
11. Bioreactors Market, by Usability
11.1. Introduction
11.2. Reusable
11.3. Single-use
12. Bioreactors Market, by End User
12.1. Introduction
12.2. Biopharmaceutical Companies & Manufacturers
12.3. Contract Manufacturing Organizations & Contract Research Organizations
12.4. Landfills & Waste Treatment Plants
12.5. R&D Departments & Institutes
13. Americas Bioreactors Market
13.1. Introduction
13.2. Argentina
13.3. Brazil
13.4. Canada
13.5. Mexico
13.6. United States
14. Asia-Pacific Bioreactors Market
14.1. Introduction
14.2. Australia
14.3. China
14.4. India
14.5. Indonesia
14.6. Japan
14.7. Malaysia
14.8. Philippines
14.9. Singapore
14.10. South Korea
14.11. Taiwan
14.12. Thailand
14.13. Vietnam
15. Europe, Middle East & Africa Bioreactors Market
15.1. Introduction
15.2. Denmark
15.3. Egypt
15.4. Finland
15.5. France
15.6. Germany
15.7. Israel
15.8. Italy
15.9. Netherlands
15.10. Nigeria
15.11. Norway
15.12. Poland
15.13. Qatar
15.14. Russia
15.15. Saudi Arabia
15.16. South Africa
15.17. Spain
15.18. Sweden
15.19. Switzerland
15.20. Turkey
15.21. United Arab Emirates
15.22. United Kingdom
16. Competitive Landscape
16.1. FPNV Positioning Matrix
16.2. Market Share Analysis, By Key Player
16.3. Competitive Scenario Analysis, By Key Player
16.3.1. Merger & Acquisition
16.3.1.1. Merger of Cytiva and Pall’s Life Sciences Business Now Complete
16.3.1.2. Merck Gains Leading Perfusion Micro-Bioreactor with Erbi Biosystems Acquisition
16.3.2. Agreement, Collaboration, & Partnership
16.3.2.1. Sartorius Bioreactors Integrate Emerson Technology to Speed New Therapies to Market
16.3.2.2. PBS Biotech and denovoMATRIX Join Forces to Boost Manufacturing Processes for Cell & Gene Therapies
16.3.2.3. Lonza and Adva Biotechnology Ltd. Agree to Expand Availability and Use of Automated Bioreactors with License to Lonza’s Patents
16.3.2.4. Solaris Biotech and Wildtype Announce Agreement for Large-scale Bioreactors for Cultivated Seafood Production
16.3.2.5. STEMCELL Technologies and PBS Biotech Partner to Enable Robust Scale Up of Human Pluripotent Stem Cell 3D Cultures
16.3.3. Investment & Funding
16.3.3.1. Novo Holdings co-leads Series C financing in LePure Biotech
16.3.3.2. PBS Biotech Raises USD 22 million to Expand Single-Use Manufacturing Products and Services for Cell Therapy Clients
16.3.3.3. Stämm Biotech Raises USD 17 Million To Develop Desktop 3D Printed Bioreactor
17. Competitive Portfolio
17.1. Key Company Profiles
17.1.1. 3D Biotek LLC
17.1.2. ABEC, Inc.
17.1.3. Adolf Kühner AG
17.1.4. BBI-biotech GmbH
17.1.5. Belach Bioteknik
17.1.6. Bioengineering AG
17.1.7. Bionet Servicios Técnicos, SL
17.1.8. Broadley-James Corporation
17.1.9. Cell Culture Company, LLC
17.1.10. Cellexus Limited
17.1.11. CerCell A/S
17.1.12. Cesco Bioengineering Co., Ltd.
17.1.13. Danaher Corporation
17.1.14. Distek, Inc.
17.1.15. Electrolab Biotech Limited
17.1.16. Eppendorf SE
17.1.17. FiberCell Systems Inc.
17.1.18. G&G Technologies, Inc.
17.1.19. GEA Group AG
17.1.20. Getinge AB
17.1.21. IKA-Werke GmbH & CO. KG
17.1.22. Infors AG
17.1.23. Lonza Group Ltd.
17.1.24. Merck KGaA
17.1.25. PBS Biotech, Inc.
17.1.26. Pierre Guérin SA
17.1.27. Praj Industries Limited
17.1.28. Sartorius AG
17.1.29. Shanghai LePure Biotech Co., Ltd.
17.1.30. Solaris Biotechnolgy Srl by Donaldson Company, Inc.
17.1.31. Solida Biotech GmBH
17.1.32. Terumo Corporation
17.1.33. Thermo Fisher Scientific Inc.
17.1.34. WuXi Biologics (Cayman) Inc.
17.1.35. ZETA GmbH
17.2. Key Product Portfolio
18. Appendix
18.1. Discussion Guide
18.2. License & Pricing